Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
University of Chicago
Novartis
Elicio Therapeutics
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Weill Medical College of Cornell University
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
Amgen
Therapeutic Advances in Childhood Leukemia Consortium
M.D. Anderson Cancer Center
Novartis
Rutgers, The State University of New Jersey
National Institutes of Health Clinical Center (CC)
Therapeutic Advances in Childhood Leukemia Consortium
Fred Hutchinson Cancer Center
Universidade Estadual Paulista Júlio de Mesquita Filho
University of Washington
Amgen Research (Munich) GmbH
SCRI Development Innovations, LLC
M.D. Anderson Cancer Center
Amgen Research (Munich) GmbH
M.D. Anderson Cancer Center